Kanneboyina Nagaraju

Kanneboyina Nagaraju
DVM, Ph.D.

Dean and Pharmaceutical Scientist

Binghamton University School of Pharmacy and Pharmaceutical Sciences

Professor Kanneboyina Nagaraju joined as the founding chair of the Department of Pharmaceutical Sciences and was one of the initial leadership members to start a new pharmacy school in 2016. His over 28 years of academic and research tenure spans the prestigious National Institutes of Health, Johns Hopkins University School of Medicine in Baltimore, George Washington University School of Medicine and Health Sciences, and Children’s National Hospital in Washington, DC. He and his colleagues are credited with discovering and developing AGAMREE (Vamorolone), a first-in-class dissociated glucocorticoid with a significantly reduced side effect profile. The Food and Drug Administration and European Medicines Agency have recently approved AGAMREE. He is an academic entrepreneur who co-founded two successful biotechnology companies, ReveraGen BioPharma Inc and Agada Biosciences and is engaged in discovering and developing therapies for neuromuscular diseases. Dr. Nagaraju is an internationally recognized leader in neuromuscular diseases (NMD). He has led international efforts to improve rigor and reproducibility by developing reliable and sensitive outcome measures to test drug efficacy in NMD models in collaboration with TREAT-NMD. He is described as an exceptional mentor and empathetic leader with outstanding interpersonal skills.

By Invitation

NACDS Foundation Pharmacy Deans Forum

Monday, April 29, 2024

2:00 PM - 4:00 PM

Magnolia Room

Pharmacy Deans

Adds overlay to page when the search is active.